MOSAIC IMMUNOENGINEERING, INC. Unrealized Gain (Loss) on Derivatives
MOSAIC IMMUNOENGINEERING, INC. (CPMV) reported Unrealized Gain (Loss) on Derivatives of $0 for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-15.
Financial Statements › Cash Flow › Operating Activities
us-gaap:UnrealizedGainLossOnDerivatives · last filed 2025-04-15
- MOSAIC IMMUNOENGINEERING, INC. unrealized gain (loss) on derivatives for the quarter ending 2024-12-31 was $0.00.
- MOSAIC IMMUNOENGINEERING, INC. unrealized gain (loss) on derivatives for the quarter ending 2024-09-30 was $0.00.
- MOSAIC IMMUNOENGINEERING, INC. unrealized gain (loss) on derivatives for the quarter ending 2023-12-31 was $0.00.
- MOSAIC IMMUNOENGINEERING, INC. unrealized gain (loss) on derivatives for the quarter ending 2023-09-30 was $0.00.
- MOSAIC IMMUNOENGINEERING, INC. unrealized gain (loss) on derivatives for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- MOSAIC IMMUNOENGINEERING, INC. unrealized gain (loss) on derivatives for fiscal 2023 was $46.70K.
| Period end | Unrealized Gain (Loss) on Derivatives 3 month | Unrealized Gain (Loss) on Derivatives 6 month | Unrealized Gain (Loss) on Derivatives 9 month | Unrealized Gain (Loss) on Derivatives 12 month |
|---|---|---|---|---|
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $0.00 10-K · filed 2025-04-15 | |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-19 | $0.00 10-Q · filed 2024-11-19 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-15 | $0.00 derived: sum of 2 quarters · filed 2025-04-15 | $46.70K 10-K · filed 2025-04-15 | |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-19 | $46.70K 10-Q · filed 2024-11-19 |